Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms

Jacquelyn M. Lykken, Mayuka Horikawa, Veronique Minard-Colin, Masahiro Kamata, Tomomitsu Miyagaki, Jonathan C. Poe, Thomas F. Tedder

Blood (2016) 127 (15): 1886–1895.

https://doi.org/10.1182/blood-2015-11-681130

Published: 2016

Journal Articles

Regulatory B Cells (B10 Cells) in Human Disease

Thomas F. Tedder, PhD

Blood (2013) 122 (21): SCI-2.

https://doi.org/10.1182/blood.V122.21.SCI-2.SCI-2

Published: 2013

Journal Articles

Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease

Doanh Le Huu, Takashi Matsushita, Guihua Jin, Yasuhito Hamaguchi, Minoru Hasegawa, Kazuhiko Takehara, Thomas F. Tedder, Manabu Fujimoto

Blood (2013) 121 (16): 3274–3283.

https://doi.org/10.1182/blood-2012-11-465658

Published: 2013

Journal Articles

Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning

Hollie J. Pegram, James C. Lee, Erik G. Hayman, Gavin H. Imperato, Thomas F. Tedder, Michel Sadelain, Renier J. Brentjens

Blood (2012) 119 (18): 4133–4141.

https://doi.org/10.1182/blood-2011-12-400044

Published: 2012

Includes: Supplemental data

Journal Articles

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

Holbrook E. Kohrt, Roch Houot, Matthew J. Goldstein, Kipp Weiskopf, Ash A. Alizadeh, Josh Brody, Antonia Müller, Russell Pachynski, Debra Czerwinski, Steven Coutre, Mark P. Chao, Lieping Chen, Thomas F. Tedder, Ronald Levy

Blood (2011) 117 (8): 2423–2432.

https://doi.org/10.1182/blood-2010-08-301945

Published: 2011

Includes: Supplemental data

Journal Articles

Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells

Yohei Iwata, Takashi Matsushita, Mayuka Horikawa, David J. DiLillo, Koichi Yanaba, Guglielmo M. Venturi, Paul M. Szabolcs, Steven H. Bernstein, Cynthia M. Magro, Armistead D. Williams, Russell P. Hall, E. William St Clair, Thomas F. Tedder

Blood (2011) 117 (2): 530–541.

https://doi.org/10.1182/blood-2010-07-294249

Published: 2011

Journal Articles

Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice

Scott E. James, Nural N. Orgun, Thomas F. Tedder, Mark J. Shlomchik, Michael C. Jensen, Yukang Lin, Philip D. Greenberg, Oliver W. Press

Blood (2009) 114 (27): 5454–5463.

https://doi.org/10.1182/blood-2009-08-232967

Published: 2009

Includes: Supplemental data

Journal Articles

An L-selectin ligand distinct from P-selectin glycoprotein ligand-1 is expressed on endothelial cells and promotes neutrophil rolling in inflammation

Akiko Shigeta, Masanori Matsumoto, Thomas F. Tedder, John B. Lowe, Masayuki Miyasaka, Takako Hirata

Blood (2008) 112 (13): 4915–4923.

https://doi.org/10.1182/blood-2008-04-153866

Published: 2008

Includes: Multimedia, Supplemental data

Journal Articles

B lymphocytes: how they develop and function

Tucker W. LeBien, Thomas F. Tedder

Blood (2008) 112 (5): 1570–1580.

https://doi.org/10.1182/blood-2008-02-078071

Published: 2008

Journal Articles

Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIV

Veronique Minard-Colin, Yan Xiu, Jonathan C. Poe, Mayuka Horikawa, Cynthia M. Magro, Yasuhito Hamaguchi, Karen M. Haas, Thomas F. Tedder

Blood (2008) 112 (4): 1205–1213.

https://doi.org/10.1182/blood-2008-01-135160

Published: 2008

Includes: Supplemental data

Journal Articles

Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase

Yuichi Aiba, Megumi Kameyama, Tetsuo Yamazaki, Thomas F. Tedder, Tomohiro Kurosaki

Blood (2008) 111 (3): 1497–1503.

https://doi.org/10.1182/blood-2007-08-109769

Published: 2008

Includes: Supplemental data

Journal Articles

Sodium Orthovanadate (NaV) Effects CD22 Expression, Intracellular Signaling, and Lymphomacidal Activity of the HB22.7 Anti-CD22 Monoclonal Antibody.

Robert T. O’Donnell, MD, PhD, David Pearson, PhD, Hayes McKnight, Thomas F. Tedder, PhD, Joseph M. Tuscano, MD

Blood (2005) 106 (11): 1487.

https://doi.org/10.1182/blood.V106.11.1487.1487

Published: 2005

Journal Articles

CD molecules 2005: human cell differentiation molecules

Blood (2005) 106 (9): 3123–3126.

https://doi.org/10.1182/blood-2005-03-1338

Published: 2005

Journal Articles

CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes

Norihito Yazawa, Manabu Fujimoto, Shinichi Sato, Kensuke Miyake, Noriko Asano, Yoshinori Nagai, Osamu Takeuchi, Kiyoshi Takeda, Hitoshi Okochi, Shizuo Akira, Thomas F. Tedder, Kunihiko Tamaki

Blood (2003) 102 (4): 1374–1380.

https://doi.org/10.1182/blood-2002-11-3573

Published: 2003

Journal Articles

Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90 Y-DOTA-peptide-Lym-1 in lymphoma xenografts

Joseph M. Tuscano, Robert T. O'Donnell, Laird A. Miers, Linda A. Kroger, David L. Kukis, Kathleen R. Lamborn, Thomas F. Tedder, Gerald L. DeNardo

Blood (2003) 101 (9): 3641–3647.

https://doi.org/10.1182/blood-2002-08-2629

Published: 2003

Journal Articles

CD22 Cross-Linking Generates B-Cell Antigen Receptor-Independent Signals That Activate the JNK/SAPK Signaling Cascade

Joseph M. Tuscano, Agostino Riva, Salvador N. Toscano, Thomas F. Tedder, John H. Kehrl

Blood (1999) 94 (4): 1382–1392.

https://doi.org/10.1182/blood.V94.4.1382

Published: 1999

NARROW

Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms

Regulatory B Cells (B10 Cells) in Human Disease

Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease

Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells

Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice

An L-selectin ligand distinct from P-selectin glycoprotein ligand-1 is expressed on endothelial cells and promotes neutrophil rolling in inflammation

B lymphocytes: how they develop and function

Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIV

Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase

Sodium Orthovanadate (NaV) Effects CD22 Expression, Intracellular Signaling, and Lymphomacidal Activity of the HB22.7 Anti-CD22 Monoclonal Antibody.

CD molecules 2005: human cell differentiation molecules

CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes

Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90 Y-DOTA-peptide-Lym-1 in lymphoma xenografts

CD22 Cross-Linking Generates B-Cell Antigen Receptor-Independent Signals That Activate the JNK/SAPK Signaling Cascade

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only